Remission of substance use disorder among psychiatric inpatients with mental illness
- PMID: 9464204
- DOI: 10.1176/ajp.155.2.239
Remission of substance use disorder among psychiatric inpatients with mental illness
Abstract
Objective: The authors assessed the nature and stability of remission of substance use disorder among persons with severe mental illness at index hospitalization and at 1-year follow-up.
Method: Consecutively admitted inpatients with severe mental illness completed the Structured Clinical Interview for DSM-III-R, Quality of Life Interview, and Addiction Severity Index at admission and 1 year later. Of the 268 patients, 70 were classified as past substance abusers in remission at baseline. Baseline characteristics and 1-year outcomes of this group were compared with those of the 109 current substance abusers and the 89 patients who were not substance abusers.
Results: The past abusers were significantly more likely to be women, and they consistently differed significantly from the current abusers in variables involving frequency of drug and alcohol use at baseline. During the follow-up period, the patients with current abuse at baseline were significantly more likely to have recurrences of substance use disorders and to use substance abuse services, and they had significantly more months of alcohol use and alcohol use to excess during follow-up than did the past abusers.
Conclusions: Baseline and follow-up assessments suggested that a substantial proportion of severely mentally ill patients with past substance use disorders are in stable remission.
Similar articles
-
Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.Am J Psychiatry. 1998 Feb;155(2):232-8. doi: 10.1176/ajp.155.2.232. Am J Psychiatry. 1998. PMID: 9464203
-
Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.Am J Psychiatry. 2004 Jul;161(7):1231-7. doi: 10.1176/appi.ajp.161.7.1231. Am J Psychiatry. 2004. PMID: 15229056
-
Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.Am J Psychiatry. 1998 Feb;155(2):226-31. doi: 10.1176/ajp.155.2.226. Am J Psychiatry. 1998. PMID: 9464202
-
Adolescent substance abuse and psychiatric comorbidities.J Clin Psychiatry. 2006;67 Suppl 7:18-23. J Clin Psychiatry. 2006. PMID: 16961420 Review.
-
Assessment of comorbid psychiatric illness and substance disorders.New Dir Ment Health Serv. 1991 Summer;(50):43-55. doi: 10.1002/yd.23319915006. New Dir Ment Health Serv. 1991. PMID: 1886549 Review. No abstract available.
Cited by
-
Patterns and Predictors of Changes in Substance Use in Individuals with Schizophrenia and Affective Disorders.J Dual Diagn. 2012 Feb 13;8(1):2-12. doi: 10.1080/15504263.2012.647466. J Dual Diagn. 2012. PMID: 22518096 Free PMC article.
-
Prevalence and clinical correlates of substance use amongst acute psychiatric inpatients in Gauteng, South Africa.S Afr J Psychiatr. 2020 Sep 25;26:1526. doi: 10.4102/sajpsychiatry.v26i0.1526. eCollection 2020. S Afr J Psychiatr. 2020. PMID: 33101728 Free PMC article.
-
Factors associated with substance use problem among Maryland Medicaid enrollees affected by serious mental illness.Addict Behav. 2009 Sep;34(9):757-63. doi: 10.1016/j.addbeh.2009.05.006. Epub 2009 May 20. Addict Behav. 2009. PMID: 19487082 Free PMC article.
-
Substance Use and Mental Health Outcomes for Comorbid Patients in Psychiatric Day Treatment.Subst Abuse. 2009 Oct 28;3:71-78. doi: 10.4137/sart.s3462. Subst Abuse. 2009. PMID: 20333262 Free PMC article.
-
Heroin detoxification with buprenorphine on an inpatient psychiatric unit.J Subst Abuse Treat. 2002 Oct;23(3):163-9. doi: 10.1016/s0740-5472(02)00244-1. J Subst Abuse Treat. 2002. PMID: 12392802 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous